Clinical Study

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report

Table 3

Volume measures assessed by the three volumetric methods ((C), (DCE), and (DWI)).

ToolAll ()Responders ()Nonresponders ()p value

(C)
 Pre-CRT [cm3]36.9 ± 34.430.6 ± 22.638.4 ± 26.6
 Post-CRT [cm3]16.7 ± 8.812.4 ± 6.920.6 ± 9.5
 Volume change [%]44.5 ± 43.060.6 ± 33.221.7 ± 46.6<0.001
(DCE)
 Pre-CRT [cm3]30.9 ± 29.131.4 ± 23.733.9 ± 25.4
 Post-CRT [cm3]18.5 ± 8.111.1 ± 6.724.7 ± 10.8
 Volume change [%]33.3 ± 38.464.0 ± 23.719.0 ± 36.9<0.001
(DWI)
 Pre-CRT [cm3]14.6 ± 12.612.5 ± 10.115.8 ± 9.3
 Post-CRT [cm3]9.0 ± 5.16.4 ± 4.47.9 ± 5.5
 Volume change [%]28.3 ± 43.148.2 ± 30.021.2 ± 44.0<0.001

Note: results are expressed as median value ± standard deviation.
Wilcoxon signed-rank test.
CRT, chemoradiation therapy; (C), conventional T2-weighted volumetry; (DWI), diffusion-weighted imaging volumetry; (DCE), dynamic contrast enhanced volumetry.